Stride Raises £4.6 Mn in Seed Funding to Expand Its Preventive Health Platform Internationally

The round included investment from Arāya Ventures, Morgan Stanley Inclusive & Sustainable Ventures, Better Ventures, Innovate UK and an investor from the a16z Scout Fund. Several angel investors also took part in the round.

Andrew Steele, founder of Stride, said, "Preventative health can sometimes sound boring or worthy, when actually it could be one of the most transformative opportunities of our generation. If we can make better health exciting, aspirational and genuinely engaging, and use deeper analysis to give people better insights earlier in life, we have the potential to change everyday behaviours at a scale that could fundamentally reshape how long and how well we live."

Stride was founded in May 2024 by Andrew Steele, an Olympic medallist and co-founder of DNAfit. The company offers a health membership designed to help people understand and manage their health.

Its platform combines DNA, blood and gut health tests with personalised health insights. These tests help users learn more about their bodies and overall wellbeing.

Stride helps people track changes in their health over time and use this information to make better decisions about their lifestyle and wellbeing.

The company aims to help people identify potential health risks early rather than waiting for problems to develop. By combining testing with personalised guidance, Stride wants to make preventive healthcare easier to access and encourage healthier daily habits.

Read Also- OlsAro Raises €5 Mn in Seed Funding to Develop Climate-Resilient Wheat Varieties